Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.99−0.01 (-0.91%)
Close on Nov 18, 2026Market cap $636.63MP/E –Yield –
Geron revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Geron's revenue for the twelve months ending Sep 30, 2024 was $29.48M, up 9199.7% year over year. For fiscal 2023 it was $237.00K, down 60.2% from the year before. Over ten years it grew -15.5% a year on average. The highest annual figure on record is $36.37M in fiscal 2015.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $237.00K | -60.2% |
| FY2022 | Dec 31, 2022 | $596.00K | -57.2% |
| FY2021 | Dec 31, 2021 | $1.39M | +450.6% |
| FY2020 | Dec 31, 2020 | $253.00K | -45.0% |
| FY2019 | Dec 31, 2019 | $460.00K | -56.8% |
| FY2018 | Dec 31, 2018 | $1.07M | +0.1% |
| FY2017 | Dec 31, 2017 | $1.07M | -82.7% |
| FY2016 | Dec 31, 2016 | $6.16M | -83.1% |
| FY2015 | Dec 31, 2015 | $36.37M | +3054.5% |
| FY2014 | Dec 31, 2014 | $1.15M | -10.1% |
| FY2013 | Dec 31, 2013 | $1.28M | -52.6% |
| FY2012 | Dec 31, 2012 | $2.71M | +11.1% |
| FY2011 | Dec 31, 2011 | $2.44M | -31.6% |
| FY2010 | Dec 31, 2010 | $3.56M | +106.4% |
| FY2009 | Dec 31, 2009 | $1.73M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $57.48M | +45.1% |
| Q1 FY2026 | Mar 31, 2026 | $51.84M | +83.4% |
| Q3 FY2025 | Sep 30, 2025 | $47.23M | +5254.5% |
| Q2 FY2025 | Jun 30, 2025 | $49.04M | +16030.3% |
| Q1 FY2025 | Mar 31, 2025 | $39.60M | +172087.0% |
| Q3 FY2024 | Sep 30, 2024 | $28.27M | +17138.4% |
| Q2 FY2024 | Jun 30, 2024 | $882.00K | +2941.4% |
| Q1 FY2024 | Mar 31, 2024 | $304.00K | +1347.6% |
| Q4 FY2023 | Dec 31, 2023 | $23.00K | -77.7% |
| Q3 FY2023 | Sep 30, 2023 | $164.00K | -44.8% |
| Q2 FY2023 | Jun 30, 2023 | $29.00K | -60.3% |
| Q1 FY2023 | Mar 31, 2023 | $21.00K | -82.9% |
| Q4 FY2022 | Dec 31, 2022 | $103.00K | -90.1% |
| Q3 FY2022 | Sep 30, 2022 | $297.00K | +172.5% |
| Q2 FY2022 | Jun 30, 2022 | $73.00K | -31.8% |
| Q1 FY2022 | Mar 31, 2022 | $123.00K | -10.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.04M | +1980.0% |
| Q3 FY2021 | Sep 30, 2021 | $109.00K | +0.9% |
| Q2 FY2021 | Jun 30, 2021 | $107.00K | +148.8% |
| Q1 FY2021 | Mar 31, 2021 | $137.00K | +163.5% |
| Q4 FY2020 | Dec 31, 2020 | $50.00K | -70.8% |
| Q3 FY2020 | Sep 30, 2020 | $108.00K | -17.6% |
| Q2 FY2020 | Jun 30, 2020 | $43.00K | -57.4% |
| Q1 FY2020 | Mar 31, 2020 | $52.00K | -8.8% |
| Q4 FY2019 | Dec 31, 2019 | $171.00K | -54.4% |
| Q3 FY2019 | Sep 30, 2019 | $131.00K | -20.6% |
| Q2 FY2019 | Jun 30, 2019 | $101.00K | -51.4% |
| Q1 FY2019 | Mar 31, 2019 | $57.00K | -82.1% |
| Q4 FY2018 | Dec 31, 2018 | $375.00K | +96.3% |
| Q3 FY2018 | Sep 30, 2018 | $165.00K | +1.2% |
| Q2 FY2018 | Jun 30, 2018 | $208.00K | +19.5% |
| Q1 FY2018 | Mar 31, 2018 | $318.00K | -40.8% |
| Q4 FY2017 | Dec 31, 2017 | $191.00K | +103.2% |
| Q3 FY2017 | Sep 30, 2017 | $163.00K | -96.8% |
| Q2 FY2017 | Jun 30, 2017 | $174.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $537.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $94.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $5.11M | – |
See a number that looks wrong?